Stojadinovic, Alexander
Cancer Vaccine Development Program,
United Kingdom
2025 Rank: 142375
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Surgery
Rank in SubField 1: 5309 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 142375 | 154739 |
| Total Cites | 12656 | 14022 |
| H-index | 63 | 66 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 3222 | 3479 |
| Number of Single+First+Last Authored Papers | 110 | 110 |
| Total Cites to Single+First+Last Authored Papers | 4714 | 5126 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11283 | 12150 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.15 |
| Self-Citation Percentage |
9.74%
|
|
Stojadinovic, Alexander
GlaxoSmithKline, USA,
United States
2023 Rank: 129505
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Surgery
Rank in SubField 1: 4964 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 129505 | 140626 |
| Total Cites | 11212 | 12499 |
| H-index | 61 | 64 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 2956 | 3210 |
| Number of Single+First+Last Authored Papers | 108 | 108 |
| Total Cites to Single+First+Last Authored Papers | 4240 | 4641 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9932 | 10746 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.16 |
| Self-Citation Percentage |
10.30%
|
|
Stojadinovic, Alexander
Uniformed Services University of the Health Sciences,
United States
2022 Rank: 124588
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Surgery
Rank in SubField 1: 4796 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 124588 | 134589 |
| Total Cites | 10248 | 11492 |
| H-index | 59 | 62 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 2768 | 3019 |
| Number of Single+First+Last Authored Papers | 108 | 108 |
| Total Cites to Single+First+Last Authored Papers | 3931 | 4323 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9070 | 9851 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.17 |
| Self-Citation Percentage |
10.82%
|
|
Stojadinovic, Alexander
Uniformed Services University of the Health Sciences,
United States
2021 Rank: 122167
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Surgery
Rank in SubField 1: 4726 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 122167 | 131497 |
| Total Cites | 9829 | 11041 |
| H-index | 58 | 61 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 2676 | 2924 |
| Number of Single+First+Last Authored Papers | 107 | 107 |
| Total Cites to Single+First+Last Authored Papers | 3797 | 4183 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8690 | 9446 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.17 |
| Self-Citation Percentage |
10.98%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.